支气管哮喘急性发作住院患者临床路径的实施与效果

Implementation and Effects of Clinical Pathway of In-patients with Acute Exacerbation of Bronchial Asthma

目的:探讨支气管哮喘临床路径的优越性。方法:抽取浙江宁波北仑人民医院2010年4月-2011年4月的哮喘患者80例,按电脑随机数字表法纳入临床路径的40例患者为观察组,选择符合标准但未纳入临床路径的40例患者为对照组。以治愈率、住院时间、住院费用为观察指标。结果:2组治愈率差异无统计学意义(P>0.05),观察组较对照组住院时间短、住院费用低,差异均有统计学意义(P<0.05)。结论:对支气管哮喘实施临床路径,能明显缩短患者住院时间,减少住院费用。

OBJECTIVE： To evaluate the superiority of bronchial asthma clinical pathway. METHODS： 80 asthma patients were collected from our hospital during Apr. 2010-Apr. 2011. By computer random number table, 40 patients involved in clinical pathway were included in observation group and 40 patients not involved in clinical pathway were included in control group. The hospital stay, the cost of hospitalization and cure rate were as index. RESULTS： There was no statistically significant difference in cure rate between 2 groups （P0.05）. But observation group had the shorter hospital stay and lower cost of hospitalization than control group, there was statistical significance （P0.05）. CONCLUSION： Bronchial asthma clinical pathway can significantly shorten the hospitalization stay and reduce hospitalization costs.